Clinical development of medicinal products for the treatment of allergic rhino-conjunctivitis

Current effective version

PDF iconAdopted guideline

Reference numberCPMP/EWP/2455/02
Effective from01/05/2005
KeywordsAllergen, seasonal and perennial allergic rhino-conjunctivitis
DescriptionThis document addresses issues of study design, efficacy and safety for new medicinal products intended for the symptomatic treatment and overall pharmacological management of allergic rhino-conjunctivitis.

Related content

How useful was this page?

Add your rating